Which nursing diagnosis should be included in the plan of care for a client taking irbesartan (Avapro)?

The inclusion of "Risk for injury" as a nursing diagnosis for a client taking irbesartan (Avapro) is particularly relevant due to the potential side effects associated with the medication. Irbesartan is an angiotensin II receptor blocker (ARB) primarily used to manage hypertension and protect kidney function in diabetic patients. One of the more significant concerns when administering this medication is the potential for orthostatic hypotension, especially during the initial phases of treatment or when the dosage is increased. This condition could lead to dizziness or fainting, thereby increasing the risk of falls and subsequent injury.

Patients may experience a decrease in blood pressure as their body adjusts to the medication, which warrants monitoring for signs of dizziness, lightheadedness, or fainting. Ensuring that the healthcare team identifies and proactively manages this risk is crucial for maintaining patient safety and preventing adverse events.

In contrast, while fluid volume deficit, risk for infection, and impaired sleep patterns may be relevant nursing considerations in the broader context of a patient's overall health management, they are not directly indicative of specific risks associated with irbesartan therapy. Maintaining awareness of potential orthostatic hypotension as a side effect of irbesartan makes the diagnostic choice of "Risk for injury" particularly pertinent